Why I think the cheap Scottish Mortgage Investment Trust and hidden gem MNG are winners

With mega-profitable US and China tech giants on one hand, and yields of 7% on the other, these two recent picks will boost any portfolio, says Tom Rodgers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Baillie Gifford’s flagship fund, the Scottish Mortgage Investment Trust (LSE:SMT) has forward-thinking investors hovering over the buy button. SMT is trading at a 3% discount to its net asset value (NAV) right now.

It is up by 124% in the last five years and up 473% over the past decade, so any opportunity to buy in at a cut-price rate is a no-brainer in my view.

Tech-hungry

The investment trust offers a technology-focused spread of stocks across the world’s two largest economies, with top holding Amazon making up 9% of the fund, closely followed by 6.1% each in Chinese internet giants Alibaba and Tencent.

NASDAQ-listed genome-sequencing life sciences firm Illumina may not be a household name, but it does boast a $43bn market cap and features with 7.5%.

Progressive investors who want some exposure to Elon Musk’s Tesla without messing around with filling out W-8BEN forms and paying outlandish charges to buy US stocks will be happy, as the electric carmaker rounds out the top five largest holdings.

Well managed

Bright spark fund manager James Anderson has made a name for himself by adding ever more Tesla in recent months, even with the volatility that stock brought to the fund.

Anyone who watched the Neil Woodford empire crumble and burn over the last year may rightly be wary of putting too much trust in one man’s vision. Certainly, favoured funds of mine like Lindsell Train Global Equity have suddenly underperformed after the Woodford Patient Capital Trust and Equity Income Fund fell from the stars to the gutter.

But there are no risky unlisted biotech stocks topping SMT’s holdings, just newly-established market leaders like Netflix, so Anderson seems to have a more sensible head on his shoulders.

As the only investment trust big enough to make it into the FTSE 100, the £7.7bn fund should be a winner if you can get it at the right price.

On my watchlist

The other FTSE 100 stock I’m buying into right now is M&G. The asset manager’s demerger from Prudential, completed on 21 October, produced only lukewarm interest in the days after the split.

I think that’s far too narrow-minded and in fact believe there’s significant upside coming to the M&G share price. The plan to pay an 11.92p dividend in 2019 would give investors a 5.6% yield at current prices, while higher dividends approaching 7% could be viable by 2021, based on a range of City analyst projections.

Chief executive John Foley has £341bn of assets under management, serving over 5 million retail customers and upwards of 750 institutional investors.

As the UK and Europe-focused end of Prudential’s saving and investments arm, M&G has fixed income on the brain, which will make a good defensive play as a host of geopolitical and monetary policy decisions (I’m looking at you, Fed) continue to make investing overall a little too much like wheeling down a never-ending rollercoaster.

While Prudential shareholders were handed shares in M&G on a one-to-one basis, even if you weren’t invited to the party to start with, I would say that new investors will find plenty to love in this asset manager.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom currently has no position in the shares covered. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »